IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

Dexcom to Host Investor Day on May 14, 2026

Greenland Mines And Its Subsidiary Major Precious Greenland A/S Join the European Raw Materials Alliance

SANDRIDGE ENERGY, INC. ANNOUNCES FIRST QUARTER 2026 OPERATIONAL AND FINANCIAL RESULTS RELEASE DATE AND CONFERENCE CALL INFORMATION

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System

Kingsway Announces Speakers for Its Investor Day on Monday, May 18 at The New York Stock Exchange

5E Advanced Materials to Host Third Fiscal Quarter 2026 Call

Intercontinental Exchange Reports April 2026 Statistics

HomeTrust Named to 2026 KBW Bank Honor Roll and Forbes’ 2026 List of America’s Best Banks

Virtuix to Lead Infantry Training Project for U.S. Marine Corps

Silicom to Participate in 21st Annual Needham Technology, Media, & Consumer Conference

Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes

UFP Packaging Expands National Pallet Manufacturing Network, Strengthening Coast-to-Coast Reach

Hansen Chosen to Deliver AI‑Enabled SaaS CIS for Los Angeles County Waterworks Districts

VyStar Credit Union Selects Diebold Nixdorf's Branch Automation Solutions to Optimize Its Self-Service Network

Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

EQB secures final approval for PC Financial acquisition and prepares for closing to bring competitive change to Canadian banking

Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease